Physician profile
Erick Michael Heiman
NPI 1184287286
$17,963.95
in general payments reported to CMS, 2019-2025
14 companies · $16K in 2025
The $16K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,549 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Travel and Lodging: $5,141 · Food and Beverage: $2,381 · Education: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Travel and Lodging | $5,140.99 |
| Food and Beverage | $2,380.95 |
| Education | $442.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,000.00 | 2025 | |
| Synthes Gmbh | $3,097.07 | 2025 | |
| Stryker Corporation | $2,738.62 | 2025 | Pro, Pangea, T2 Alpha |
| Medical Device Business Services, INC. | $442.01 | 2024 | Stratafix |
| Depuy Synthes Sales INC. | $403.00 | 2024-2025 | Na, Va-Lcp |
| Kerecis Limited | $334.91 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Carbofix Orthopedics INC | $230.83 | 2025 | |
| Ethicon US, LLC | $181.80 | 2024 | Stratafix, Vistaseal, Ethicon |
| Sanara Medtech INC. | $150.64 | 2025 | Celleraterx |
| Axogen | $143.56 | 2024 | Axoguard Nerve Cap, Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector |
| Zimmer Biomet Holdings, INC. | $136.02 | 2024 | A.L.P.S. |
| Smith+Nephew, INC. | $47.30 | 2025 | Evos |
| Illuminoss Medical, INC. | $30.26 | 2024 | |
| Titan Surgical Group, LLC | $27.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erick Heiman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.